« Back
Home /
Anti-KIR2DL1 / CD158a Reference Antibody (Innate patent anti-KIR2DL)

Anti-KIR2DL1 / CD158a Reference Antibody (Innate patent anti-KIR2DL)

Item no.	ABC-APR10967
Manufacturer	Abcepta
Amount	100 ug
Category	Oncology By Cell Type Hematology Myeloma Flow Cytometry ELISA Immunostaining
Type	Antibody Primary
Applications	FC, ELISA
Specific against	Human (Homo sapiens)
Host	CHO cells
Isotype	IgG1
Conjugate/Tag	Unconjugated
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Available
Manufacturer - Applications	FC, E, FTA
Manufacturer - Category	Primary Antibodies
Manufacturer - Targets	KIR2DL1 / CD158a
Clonality	Monoclonal
Gene Name	KIR2DL1
Subtitle	Recombinant Antibody
Reactivity	Cynomolgus, H
Calculated Molecular Weight	150
Concentration	1mg/ml
Endotoxin	< 0.001EU/μg, determined by LAL method.
Manufacturer - Alias	Killer cell immunoglobulin-like receptor 2DL1, CD158 antigen-like family member A, Natural killer-associated transcript 1, NKAT-1, p58 natural killer cell receptor clones CL-42/47.11, p58 NK receptor CL-42/47.11, p58.1 MHC class-I-specific NK receptor, CD158a, KIR2DL1 (), CD158A, NKAT1

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-APR10967-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

available

Delivery expected until 3/5/2026

Express Delivery: Save 8 days

Compare

Add to wishlist

Get an offer